Corvus Pharmaceuticals CRVS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$44.17M-189% | -$15.28M-1.4% | -$15.08M+66.6% | -$45.14M-9.0% | -$41.4M+33.5% | ||
| $112K+6.7% | $105K+6.1% | $99K+7.6% | $92K+9.5% | $84K-1.2% | ||
| $6.73M+26.2% | $5.33M+16.7% | $4.57M+12.7% | $4.05M+13.7% | $3.57M+18.7% | ||
| -$34.91M-6.4% | -$32.8M-2.3% | -$32.07M-11.3% | -$28.83M-1.0% | -$28.53M-12.2% | ||
| $229K+31.6% | $174K— | —— | —— | —— | ||
| —— | —— | -$24.76M+4.9% | -$26.03M-12.0% | -$23.23M+15.5% | ||
| $226.9M+523% | $36.43M-33.8% | $55.02M+0.6% | $54.71M— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$35.14M-6.6% | -$32.97M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Corvus Pharmaceuticals generate?
- Corvus Pharmaceuticals (CRVS) generated -$34.9M in operating cash flow over the trailing twelve months.
- What is Corvus Pharmaceuticals's free cash flow?
- After $229.0K of capital expenditures, Corvus Pharmaceuticals's free cash flow was -$35.1M over the trailing twelve months, down 45.7% year over year.
- Where does Corvus Pharmaceuticals's cash flow data come from?
- Every line is extracted from Corvus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.